Rsls earnings

Author: xaul

August undefined, 2024

WebMar 23, 2024 · ReShape Lifesciences Inc. (RSLS) latest earnings report: revenue, EPS, surprise, history, news and analysis. WebAug 5, 2024 · For the three months ended June 30, 2024, the Company reported revenues of $3.5 million, as compared to revenues of $1.7 million in the three months ended June 30, 2024, representing a 107%...

RSLS - Reshape Lifesciences Stock Price - Barchart.com

WebOn Nov 14, 2024, Reshape Lifesciences ( NASDAQ: RSLS) reported Q3 2024 earnings per share (EPS) of -$26.00, up 50% year over year. Total Reshape Lifesciences earnings for … Web8 rows · ReShape Lifesciences Inc. (RSLS) NasdaqCM - NasdaqCM Real Time Price. Currency in USD. Follow. 2W ... exterior wood white paint

Head to Head Review: ReShape Lifesciences (OTCMKTS:RSLS) …

WebApr 14, 2024 · RSLS ReShape Lifesciences Inc. Stock Price & Overview $2.59 -0.19 ( -6.68%) 3:39 PM 03/17/23 NASDAQ $USD Delayed Summary Ratings Financials Earnings … WebRSLS Stock Price - ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. ... It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. ReShape Lifesciences Inc.'s EBITDA is -0.03. WebApr 11, 2024 · Gross Revenue: Price/Sales Ratio: Net Income: Earnings Per Share: Price/Earnings Ratio: ReShape Lifesciences: $13.60 million: 0.10-$61.93 million ($197.50) … exteris bayer

ReShape Lifesciences Inc. (RSLS) - Yahoo Finance

RSLS Price/Earnings & PEG Ratios - Nasdaq

Web29 rows · Mar 17, 2024 · ReShape Lifesciences (OTCMKTS:RSLS) has a recorded net income of -$61.93 million. RSLS has ... WebApr 11, 2024 · OTCMKTS:RSLS ReShape Lifesciences - RSLS Price Target & Analyst Ratings $2.75 +0.06 (+2.23%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $2.63 $2.87 50-Day Range $2.57 $17.04 52-Week Range $2.49 $65.00 Volume 86,606 shs Average Volume 805,389 shs Market Capitalization $1.43 million P/E Ratio N/A Dividend Yield N/A … exteriro foam on footbal helmetsWebMar 24, 2024 · ReShape Lifesciences Inc. (RSLS) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts. exterity c1520

"WebRSLS Earnings Date Earnings Per Share Estimated Reported Quarterly Earnings Surprise Amount Yearly Earnings Forecast Quarterly Earnings Forecast Change in Consensus … " - Rsls earnings

Rsls earnings

Events and Presentations ReShape Lifesciences

WebApr 12, 2024 · Brenmiller Energy (BNRG) -19%.GlucoTrack (GCTK) -16%.Innovative Eyewear (LUCY) -16% files patent For chatGPT enabled smart eyewear.Nouveau Monde Graphite NMG -14% launches stock offering... WebMar 23, 2024 · RSLS ReShape Lifesciences Inc. Earnings Date & History +3.97% 3:59 PM 03/23/23 NASDAQ $USD Post-Market: $3.19 +0.05 (+1.59%) 7:56 PM Earnings …

Did you know?

WebApr 11, 2024 · ReShape Lifesciences (RSLS) Earnings Date & Reports 375 Followers Portfolio Earnings Data Report Date Apr 11, 2024 Before Open Not Confirmed Period … WebApr 11, 2024 · SAN CLEMENTE, Calif., April 11, 2024 (GLOBE NEWSWIRE) — ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application 16/792,094, …

Web04/14 Barron's First-Quarter Earnings: Gloomy, With a Silver Lining. 04/14 Norway expels 15 Russian diplomats suspected of spying WebRSLS +500% upside potential according to this analyst RSLS, ReShape Lifesciences, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.

WebApr 10, 2024 · INTUITIVE SURGICAL, INC. : Q1 2024 Earnings Release (Projected) 04/25/23: DANAHER CORPORATION : Q1 2024 Earnings Release: 04/26/23: THERMO FISHER SCIENTIFIC INC. : Q1 2024 Earnings Release (Projected) 04/26/23: BOSTON SCIENTIFIC CORPORATION : Q1 2024 Earnings Release (Projected) WebReShape Lifesciences Inc. (RSLS) Analyst Forecast RSLS Price, Volume, Earnings, and Dividend Date Last Price $2.93 Previous Close $3.12 Change $-0.19 Open $2.87 Volume 97,946 Avg. Volume (100-day) 543,614 Market Cap 5,257,000 Days Range 2.8 - 2.95 52-week Range 2.49 - 77 Dividend Yield — Ex. Dividend Date — P-E — EPS — Earnings Date 06/27/23

WebNext quarter’s earnings estimate for RSLS is -$10.00 with a range of -$10.50 to -$9.50. The previous quarter’s EPS was -$29.25. RSLS beat its EPS estimate 0.00% of the time in the …

WebEarnings; IPO Calendar; Dividend Calendar; SPO Calendar; Holiday Calendar; Analyst Activity Analyst Recommendations; Daily Earnings Surprise; Forecast Changes; Commodities. … exterity boxWebMar 28, 2024 · RSLS 24O0 SAN CLEMENTE, Calif., March 28, 2024 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. ( Nasdaq: RSLS ), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will delay its year ended December 31, 2024 earnings release and conference call, previously scheduled for 8:00 … exterity artiosignWebApr 11, 2024 · Gross Revenue: Price/Sales Ratio: Net Income: Earnings Per Share: Price/Earnings Ratio: ReShape Lifesciences: $13.60 million: 0.10-$61.93 million ($197.50)-0.01 exterior worlds landscaping \\u0026 design